HIV pre-exposure prophylaxis for people who inject drugs: a review of current results and an agenda for future research.

ABSTRACT:

Introduction

Studies examining the use of pre-exposure prophylaxis (PrEP) to prevent HIV transmission among people who inject drugs (PWIDs) have not been adequately summarized. Recently, the Bangkok Tenofovir Study has shown that PrEP may be effective at reducing new HIV infections among this high-risk group. This randomized controlled trial was the first study to specifically examine the efficacy of PrEP among PWIDs. In this review, we present the current state of evidence regarding the use of PrEP to prevent HIV infection in PWID populations, and set an agenda for future research to inform the most effective implementation of PrEP in the context of existing evidence-based HIV prevention strategies.

Discussion

Despite positive trial results confirming that PrEP may prevent

SUBMITTER: Escudero DJ 

PROVIDER: S-EPMC3969508 | biostudies-literature | 2014

REPOSITORIES: biostudies-literature